NR4A1 and neoplasm: 2 (axillary dissection), ex-3 (complete tumour staging data), 5 (hormone receptor assessment) and 7.1a (adjuvant and neoadjuvant chemotherapy at age ≤ 70 years) had high initial levels and either remained essentially unchanged at about the first-year DKG/DGS level (No. 2) or improved further to achieve levels close to (Nos.